Plain-English translation of NCT06031714 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing an innovative approach called "natural stem therapy" that aims to activate fetal stem cells that remain in your body after pregnancy to help heal difficult wounds. The treatment uses a natural chemical messenger (CCL2) injected into the wound to recruit these healing cells to the injury site. This study will help determine whether this approach is safe and effective before moving to larger clinical trials.
Many women experience chronic wounds—such as diabetic ulcers, venous ulcers, or sickle cell-related ulcers—that don't heal well with standard treatments. Rather than relying on complicated stem cell cultures that carry risks of infection or genetic changes, this research explores using your body's own natural reservoir of healing cells that have been present since pregnancy, offering a simpler and potentially safer alternative.
You likely qualify if…
You likely don't qualify if…
If you have a chronic wound, you will be asked to provide blood and/or saliva samples, and researchers will monitor your wound healing after receiving the natural stem cell-activating treatment. If you are in the control group (postpartum women without wounds), you will provide matching blood and/or saliva samples for comparison. The study is currently recruiting participants and will involve visits to provide samples and allow monitoring of healing progress.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France